Adductor spasmod.ic dysphonia is a vocal disorder of uncertain etiology with no satisfactory long-term treatment-result. Recently injecrton of Botulinum toxin (BOTOX) into the thyroarytenoid muscle has been used as an effective temporary treatment. In this experiment, 9 partents with adductor spasmodic dysphonia (SPD) were studicd and injected percutaneously the Bonlinum toxin with dose of injection ranges from 1.25 to 5 units totally. Post 
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The acoustic feature of a voice sample analyzed using Statistical analysis showed that post-BOTOX injection the PPQ was decreased significantly (P<0.0001), but still higher compared to normal voices.
The bar plot of Log10 amplitude perturbation quotient (APQ), for the whole groups was showed in figure 3.
After injection, the APQ (mean value 0.379, SD 0.379) was unsignificantly decreased (P>0.005) compared to before injection (mean value 0.401, SD 0.374). However, compared to the normal control (mean 0.142, SD 0.246) the difference is significant (P<0.0001). 
